Chemoinformaics analysis of 1-Acetoxy-2-Hydroxy-4-Oxoheneicosa-12,15-Diene
Molecular Weight | 380.569 | nRot | 18 |
Heavy Atom Molecular Weight | 340.249 | nRig | 4 |
Exact Molecular Weight | 380.293 | nRing | 0 |
Solubility: LogS | -4.841 | nHRing | 0 |
Solubility: LogP | 5.992 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 67 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 23 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 68.2897 |
nHD | 1 | BPOL | 43.6003 |
QED | 0.189 |
Synth | 3.12 |
Natural Product Likeliness | 1.637 |
NR-PPAR-gamma | 0.967 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.028 |
Pgp-sub | 0.248 |
HIA | 0.026 |
CACO-2 | -4.638 |
MDCK | 0.000026 |
BBB | 0.836 |
PPB | 0.97042 |
VDSS | 0.944 |
FU | 0.029217 |
CYP1A2-inh | 0.379 |
CYP1A2-sub | 0.147 |
CYP2c19-inh | 0.27 |
CYP2c19-sub | 0.058 |
CYP2c9-inh | 0.493 |
CYP2c9-sub | 0.905 |
CYP2d6-inh | 0.015 |
CYP2d6-sub | 0.069 |
CYP3a4-inh | 0.694 |
CYP3a4-sub | 0.067 |
CL | 7.572 |
T12 | 0.654 |
hERG | 0.03 |
Ames | 0.585 |
ROA | 0.003 |
SkinSen | 0.953 |
Carcinogencity | 0.45 |
EI | 0.35 |
Respiratory | 0.56 |
NR-Aromatase | 0.459 |
Antiviral | Yes |
Prediction | 0.814794 |